Kanarek, N
As more molecules cluster near that threshold, efficacy looks increasingly like a baseline expectation rather than a lasting edge
Raghavendra Tirupathi, and medical students studying under him, Shruti Vadali, Shanthi Reddy and Avinash Javajji, discuss how these medications work, who may be a good candidate, and more
Originally used to treat diabetes, GLP-1s have become an attractive option for those looking to suppress hunger and shed pounds fast
Suicidal death of erythrocytes in cancer and its chemotherapy: a potential target in the treatment of tumor-associated anemia
Still, their popularity is growing fuelled by testimonials, influencer hype and the seductive promise of turning back time